[1]
M. Alsieni, “ Saudi Arabia: a Descriptive Cross-Sectional Study: The prevalence of Glucagon-like Peptide-1 (GLP-1) Agonists use as an Obesity Treatment among adults in Saudi Arabia”., JKAU Med Sci, vol. 31, no. 2, Dec. 2024.